Eplerenone, an Aldosterone Antagonist, Reduces Hospitalization and Death in Heart Failure Patients With Nyha Class II and an Ejection Fraction of Less Than 30%
Internal and Emergency Medicine - Italy
doi 10.1007/s11739-011-0661-0
Full Text
Open PDFAbstract
Available in full text
Date
July 17, 2011
Authors
Publisher
Springer Science and Business Media LLC